A candidate gene approach to searching for low-penetrance breast and prostate cancer genes

被引：143
作者：
Hunter, DJ [1 ]
Riboli, E [1 ]
Haiman, CA [1 ]
Albanes, D [1 ]
Altshuler, D [1 ]
Chanock, SJ [1 ]
Hayes, RB [1 ]
Henderson, BE [1 ]
Kaaks, R [1 ]
Stram, DO [1 ]
Thomas, G [1 ]
Thun, MJ [1 ]
机构：
[1] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA
来源：
NATURE REVIEWS CANCER | 2005年 / 5卷 / 12期
关键词：
D O I：
10.1038/nrc1754
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Most cases of breast and prostate cancer are not associated with mutations in known high-penetrance genes, indicating the involvement of multiple low-penetrance risk alleles. Studies that have attempted to identify these genes have met with limited success. The National Cancer Institute Breast and Prostate Cancer Cohort Consortium - a pooled analysis of multiple large cohort studies with a total of more than 5,000 cases of breast cancer and 8,000 cases of prostate cancer - was therefore initiated. The goal of this consortium is to characterize variations in approximately 50 genes that mediate two pathways that are associated with these cancers - the steroid-hormone metabolism pathway and the insulin-like growth factor signalling pathway - and to associate these variations with cancer risk.
引用
收藏
页码：977 / 985
页数：9
相关论文
共 97 条
  • [1] Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
    Anderson, GL
    Limacher, M
    Assaf, AR
    Bassford, T
    Beresford, SAA
    Black, H
    Bonds, D
    Brunner, R
    Brzyski, R
    Caan, B
    Chlebowski, R
    Curb, D
    Gass, M
    Hays, J
    Heiss, G
    Hendrix, S
    Howard, BV
    Hsia, J
    Hubbell, A
    Jackson, R
    Johnson, KC
    Judd, H
    Kotchen, JM
    Kuller, L
    LaCroix, AZ
    Lane, D
    Langer, RD
    Lasser, N
    Lewis, CE
    Manson, J
    Margolis, K
    Ockene, J
    O'Sullivan, MJ
    Phillips, L
    Prentice, RL
    Ritenbaugh, C
    Robbins, J
    Rossouw, JE
    Sarto, G
    Stefanick, ML
    Van Horn, L
    Wactawski-Wende, J
    Wallace, R
    Wassertheil-Smoller, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14): : 1701 - 1712
  • [2] AUSTIN H, 1991, CANCER RES, V51, P568
  • [3] Ball P, 1980, Acta Endocrinol Suppl (Copenh), V232, P1
  • [4] Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
  • [5] ENDOGENOUS HORMONES AND BREAST-CANCER RISK
    BERNSTEIN, L
    ROSS, RK
    [J]. EPIDEMIOLOGIC REVIEWS, 1993, 15 (01) : 48 - 65
  • [6] Insulin like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast
    Bohlke, K
    Cramer, DW
    Trichopoulos, D
    Mantzoros, CS
    [J]. EPIDEMIOLOGY, 1998, 9 (05) : 570 - 573
  • [7] Bosland M C, 1996, Prog Clin Biol Res, V394, P309
  • [8] Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease
    Botstein, D
    Risch, N
    [J]. NATURE GENETICS, 2003, 33 (Suppl 3) : 228 - 237
  • [9] Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5
  • [10] The American Cancer Society cancer prevention study II nutrition cohort - Rationale, study design, and baseline characteristics
    Calle, EE
    Rodriguez, C
    Jacobs, EJ
    Almon, ML
    Chao, A
    McCullough, ML
    Feigelson, HS
    Thun, MJ
    [J]. CANCER, 2002, 94 (09) : 2490 - 2501
12345678910